Target intelligence / Profile preview

Sorting nexin-9 (SNX9)

Target
SNX9
Molecular classification
Adaptor protein, Sorting nexin family, Membrane remodeling protein, PX-BAR protein, Scaffold protein
01

Overview

Sorting nexin-9 is a multifunctional adaptor protein encoded by the *SNX9* gene in humans[1][2][3]. It is a member of the sorting nexin family, characterized by the presence of a phosphoinositide-binding Phox (PX) domain and a Bin-Amphiphysin-Rvs (BAR) domain, which are essential for sensing and inducing membrane curvature[1][5][7]. SNX9 plays a central role in clathrin-mediated endocytosis, acting as a scaffold that recruits dynamin, clathrin, and adaptor complexes such as AP-2 to sites of vesicle formation at the plasma membrane[1][5][7][8]. Its Src homology 3 (SH3) domain mediates interactions with proteins including dynamin and N-WASP, thereby linking vesicle trafficking to actin cytoskeleton remodeling[4][7]. SNX9 is also involved in several cellular processes beyond endocytosis, such as regulation of cell migration, cytokinesis, and angiogenesis, partly by participating in actin polymerization and recycling adhesion receptors[1][6]. In the context of disease, altered SNX9 activity and expression have been linked to enhanced metastasis in cancer, chronic inflammation, and modulation of immune status[6][4]. There are currently no known drugs directly targeting SNX9, and it is not a primary therapeutic target like a receptor or enzyme.

Other names
SNX9Sorting nexin 9Sorting nexin-9SH3PX1
02

Biological functions

Clathrin-mediated endocytosisMembrane traffickingScaffold for protein–protein interactionsActin cytoskeleton remodelingMacropinocytosisRegulation of receptor internalizationCytokinesis and mitosis
03

Disease associations

Cancer (especially metastasis, invasion)Chronic inflammationWiskott-Aldrich syndrome (as related pathway component)Infection (e.g., viral uptake)Other (implicated in cell migration and angiogenesis)
04

Biomarkers

Altered SNX9 expression may be an indicator of immune status in chronic inflammation, and increased expression is associated with metastasis in certain cancers[6][4]

Beyond the preview

Go deeper on Sorting nexin-9 (SNX9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorting nexin-9 (SNX9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call